Best Practices and Research Advances in Thoracic Oncology: A Regional Series SE Asia Course 1: Liquid Biopsy in Lung Cancer-Liquid Biopsy in the Region

Video Transcription

Video Summary

Dr. Sevanti Lemai discusses advances in thoracic oncology, emphasizing the transformative role of liquid biopsies in lung cancer management. Liquid biopsies offer minimally invasive methods for screening, prognosis, treatment monitoring, and detecting molecular evolution. They simplify the diagnosis and management of lung cancer, especially in advanced cases where traditional biopsies pose challenges. Dr. Lemai shares a case study of a 40-year-old non-smoker with advanced NSCLC, highlighting the effectiveness of liquid biopsies in identifying actionable mutations and guiding targeted therapies, leading to sustained responses. She notes the availability of international and local liquid biopsy tests in India, with local labs providing cost-effective options. Dr. Lemai emphasizes the need for a precision oncology approach in India, given its rising cancer incidence. She advocates for a hub-and-spoke healthcare model to enhance cancer care delivery and integrate genomic technology, aiming to improve patient outcomes significantly.

Asset Subtitle

Sewanti Limaye, MBBS, MD, MS

Keywords

thoracic oncology

liquid biopsies

lung cancer

precision oncology

NSCLC

genomic technology